Photo by alessandro_debellis from unsplash
Nonantigen‐specific immunoadsorption (IA) has proven to be effective in acute antibody‐mediated rejection (aAMR). However, there is a lack of solid studies evaluating the safety and efficacy of IA with antihuman… Click to show full abstract
Nonantigen‐specific immunoadsorption (IA) has proven to be effective in acute antibody‐mediated rejection (aAMR). However, there is a lack of solid studies evaluating the safety and efficacy of IA with antihuman Ig‐columns in aAMR. For chronic‐active AMR (cAMR), no studies have evaluated the efficacy of nonantingen‐specific IA with antihuman Ig‐columns. The purpose of this study was to evaluate the role of nonantigen‐specific IA with antihuman Ig‐columns in the treatment of both aAMR and cAMR in kidney transplantation.
Journal Title: Journal of Clinical Apheresis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!